Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma [Phase 2]
This update reports results from a Phase 2 trial of ixabepilone in relapsed or refractory aggressive non-Hodgkin lymphoma across multiple su…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab with combination chemotherapy in stage II-IV diffuse large B-cell non-Hodgkin's lymphoma has completed wi…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 trial evaluating the combination of tanespimycin and bortezomib in adults with advanced solid tumors or lymphomas; the study was ter…
-
CLINICAL_TRIALS other · 2014-02-12Clinical Trial Update: Epstein-Barr Virus Status in Diffuse Large B Cell Lymphoma
A status update for the clinical trial NCT02060435 reporting Epstein-Barr Virus status in Diffuse large B-cell lymphoma, with the study stat…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating CCI-779 (temsirolimus) in patients with recurrent or refractory B-cell non-Hodgkin lymphoma or chronic l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma [Phase 1]
A Phase 1 clinical trial of a radiolabeled monoclonal antibody for patients with previously treated large cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma [Phase 3]
Phase 3 trial evaluating GM-CSF with or without a Favrille vaccine after first-line chemotherapy and rituximab in diffuse large B-cell lymph…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of a geldanamycin analogue in patients with advanced solid tumors or Non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Sunitinib in Treating Patients With Relapsed or Refractory Diffuse or Mediastinal Large B-Cell Lymphoma [Phase 2]
This Phase 2 trial assessed the use of sunitinib in adults with relapsed or refractory diffuse large B-cell lymphoma, including mediastinal …
-
CLINICAL_TRIALS withdrawal · 2013-12-10Clinical Trial Update: Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement. [Phase 2]
This Phase 2 trial evaluating Rituximab-HyperCVAD alternating with Rituximab-Methotrexate-Cytarabine for newly diagnosed diffuse large B-cel…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma [Phase 2]
Phase 2 study evaluating two Velcade-based regimens with Rituximab and chemotherapy (cyclophosphamide, doxorubicin, prednisone) or with vinc…
-
CLINICAL_TRIALS research · 2013-11-21Clinical Trial Update: Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With DLBCL: a Phase II Multicenter Study of the FIL [Phase 2]
Phase II multicenter trial by Fondazione Italiana Linfomi evaluating frontline rituximab plus bendamustine in frail elderly patients over 70…
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: Early Treatment Stratification Based on PET Scan Response to Chemotherapy in Patients With Diffuse Large B-cell Lymphoma [Phase 2]
This Phase 2 clinical trial update describes using PET scan response to guide early treatment decisions in patients with diffuse large B-cel…
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects [Phase 1]
A Phase 1, double-blind, randomized controlled study in CD20-positive diffuse large B-cell lymphoma has completed.
-
CLINICAL_TRIALS research · 2013-10-22Clinical Trial Update: Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients
An observational study was completed evaluating cytofluorimetric analysis of cerebrospinal fluid in patients with non-Hodgkin's lymphoma.
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 trial evaluating combination chemotherapy with rituximab in children with recurrent or refractory B-cell non-Hodgkin lymphoma or acu…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial evaluating Triapine (3-AP) in combination with gemcitabine in patients with advanced solid tumors or lymphoma has completed. I…
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma [Phase 2]
Multicenter Phase 2 trial comparing R-CHOP versus R-COP in patients with Diffuse Large B-Cell Lymphoma to assess cardiotoxicity; the study h…
-
CLINICAL_TRIALS withdrawal · 2013-08-26Clinical Trial Update: Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Se-Methyl-Seleno-L-Cysteine with Rituximab, Ifosfamide, Carboplatin, and Etoposide for relapsed or tre…
-
CLINICAL_TRIALS withdrawal · 2013-07-25Clinical Trial Update: Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly [NA]
A clinical trial evaluating Brentuximab vedotin for CD30-positive EBV-positive diffuse large B-cell lymphoma in elderly patients has been wi…
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas [Phase 2]
A Phase 2 trial assessing the efficacy and safety of R NIMP in relapsed aggressive lymphomas, including diffuse large B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2013-07-04Clinical Trial Update: Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 2]
A Phase 2 study evaluating SyB L-0501 in combination with Rituximab for relapsed/refractory diffuse large B-cell lymphoma has completed, wit…
-
CLINICAL_TRIALS withdrawal · 2013-06-25Clinical Trial Update: GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating GCS-100LE in combination with etoposide and dexamethasone for relapsed or refractory diffuse large B-cell lymph…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating rituximab in combination with chemotherapy for relapsed or refractory diffuse large B-cell lymphoma has completed…
-
CLINICAL_TRIALS research · 2013-06-13Clinical Trial Update: Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab [NA]
This clinical trial randomized adults with diffuse large B-cell lymphoma to high-dose chemotherapy with rituximab versus CHOP-14 chemotherap…